Avantra Family Wealth, Inc. Astrazeneca PLC Transaction History
Avantra Family Wealth, Inc.
- $104 Billion
- Q1 2025
A detailed history of Avantra Family Wealth, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Avantra Family Wealth, Inc. holds 6,369 shares of AZN stock, worth $451,944. This represents 0.45% of its overall portfolio holdings.
Number of Shares
6,369
Previous 9,100
30.01%
Holding current value
$451,944
Previous $596 Million
21.49%
% of portfolio
0.45%
Previous 0.56%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.05 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.89 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.53 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.26 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.22 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $220B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...